[e-mail]

Mannkind: Overlooked Biotech With Excellent Prospects (Part V)

Your diligence and effort are extraordinary. But the fact remains this is inhaling a growth factor and experts are going to worry, no matter what the data shows. If its 2 years of clean data, they'll say fine, but how do you know what will happen 5, 10, 20 years out for a therapy taken for life? How do they go about changing perceptions? Am I missing the forest for the trees or are you?